Literature DB >> 23997308

Evaluation of the novel respiratory virus surveillance program: Pediatric Early Warning Sentinel Surveillance (PEWSS).

Patricia A Armour1, Linh M Nguyen, Michelle L Lutman, John P Middaugh.   

Abstract

OBJECTIVES: Infections caused by respiratory viruses are associated with recurrent epidemics and widespread morbidity and mortality. Routine surveillance of these pathogens is necessary to determine virus activity, monitor for changes in circulating strains, and plan for public health preparedness. The Southern Nevada Health District in Las Vegas, Nevada, recruited five pediatric medical practices to serve as sentinel sites for the Pediatric Early Warning Sentinel Surveillance (PEWSS) program.
METHODS: Sentinel staff collected specimens throughout the year from ill children who met the influenza-like illness case definition and submitted specimens to the Southern Nevada Public Health Laboratory for molecular testing for influenza and six non-influenza viruses.
RESULTS: Laboratory results were analyzed and reported to the medical and general communities in weekly bulletins year-round. PEWSS data were also used to establish viral respiratory seasonal baselines and in influenza vaccination campaigns. The surveillance program was evaluated using the Centers for Disease Control and Prevention's (CDC's) Updated Guidelines for Evaluating Public Health Surveillance Systems. PEWSS met three of six program usefulness criteria and seven of nine surveillance system attributes, which exceeded the CDC Guidelines evaluation criteria for a useful and complete public health surveillance program.
CONCLUSION: We found that PEWSS is a useful and complete public health surveillance system that is simple, flexible, accessible, and stable.

Entities:  

Mesh:

Year:  2013        PMID: 23997308      PMCID: PMC3730010          DOI: 10.1177/00333549131280S213

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  17 in total

1.  Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients.

Authors:  Peter Daley; Santina Castriciano; Max Chernesky; Marek Smieja
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit.

Authors:  Natasha B Halasa; John V Williams; Gregory J Wilson; William F Walsh; William Schaffner; Peter F Wright
Journal:  Pediatr Infect Dis J       Date:  2005-12       Impact factor: 2.129

Review 3.  Zoonotic viral diseases and the frontier of early diagnosis, control and prevention.

Authors:  J L Heeney
Journal:  J Intern Med       Date:  2006-11       Impact factor: 8.989

4.  Association of rhinovirus infection with increased disease severity in acute bronchiolitis.

Authors:  Nikolaos G Papadopoulos; Maria Moustaki; Mariza Tsolia; Apostolos Bossios; Eleni Astra; Anargiroula Prezerakou; Dimitrios Gourgiotis; Dimitrios Kafetzis
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

5.  Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections.

Authors:  Anja Wilkesmann; Oliver Schildgen; Anna Maria Eis-Hübinger; Tilman Geikowski; Thomas Glatzel; Michael J Lentze; Udo Bode; Arne Simon
Journal:  Eur J Pediatr       Date:  2006-03-23       Impact factor: 3.183

6.  Clinical disease in children associated with newly described coronavirus subtypes.

Authors:  Jane Kuypers; Emily T Martin; Judson Heugel; Nancy Wright; Rhoda Morrow; Janet A Englund
Journal:  Pediatrics       Date:  2006-11-27       Impact factor: 7.124

7.  Respiratory illness associated with influenza and respiratory syncytial virus infection.

Authors:  D M Fleming; R S Pannell; A J Elliot; K W Cross
Journal:  Arch Dis Child       Date:  2005-04-26       Impact factor: 3.791

8.  Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus.

Authors:  Bo Shu; Kai-Hui Wu; Shannon Emery; Julie Villanueva; Roy Johnson; Erica Guthrie; LaShondra Berman; Christine Warnes; Nathelia Barnes; Alexander Klimov; Stephen Lindstrom
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

9.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection.

Authors:  Jorge Garbino; Sophie Crespo; J-D Aubert; Thierry Rochat; Beatrice Ninet; Christelle Deffernez; Werner Wunderli; Jean-Claude Pache; Paola M Soccal; Laurent Kaiser
Journal:  Clin Infect Dis       Date:  2006-09-13       Impact factor: 9.079

View more
  4 in total

1.  Public health laboratory systems: at the crossroads.

Authors:  John C Ridderhof; Burton W Wilcke
Journal:  Public Health Rep       Date:  2013 Sep-Oct       Impact factor: 2.792

Review 2.  Control Measures for Human Respiratory Viral Infection.

Authors:  Lesley Bennett; Grant Waterer
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

3.  MoSAIC: Mobile Surveillance for Acute Respiratory Infections and Influenza-Like Illness in the Community.

Authors:  Melissa S Stockwell; Carrie Reed; Celibell Y Vargas; Stewin Camargo; Aaron F Garretson; Luis R Alba; Philip LaRussa; Lyn Finelli; Elaine L Larson; Lisa Saiman
Journal:  Am J Epidemiol       Date:  2014-12-15       Impact factor: 4.897

Review 4.  Surveillance for emerging respiratory viruses.

Authors:  Jaffar A Al-Tawfiq; Alimuddin Zumla; Philippe Gautret; Gregory C Gray; David S Hui; Abdullah A Al-Rabeeah; Ziad A Memish
Journal:  Lancet Infect Dis       Date:  2014-09-01       Impact factor: 25.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.